reglab/statecodes huggingface dataset:
Code of Maryland Regulations › Title 10 - MARYLAND DEPARTMENT OF HEALTH › Part 5 › Subtitle 62 - NATALIE M. LAPRADE MEDICAL CANNABIS COMMISSION › Chapter 10.62.30 - Dispensing Medical Cannabis › Section 10.62.30.08 - Disposal of Green Waste

Current through Register Vol. 51, No. 14, July 12, 2024
A licensee may either:
A. Ship any medical cannabis that is surplus
				  or out of date or that is waste from processing or repackaging to a licensed
				  grower for disposal; or
B. Dispose
				  of such material in accordance with the licensee's approved waste disposal
				  plan.
Code of Maryland Regulations › Title 10 - MARYLAND DEPARTMENT OF HEALTH › Part 5 › Subtitle 62 - NATALIE M. LAPRADE MEDICAL CANNABIS COMMISSION › Chapter 10.62.30 - Dispensing Medical Cannabis › Section 10.62.30.09 - Deli-Style Sales of Medical Cannabis

Current through Register Vol. 51, No. 14, July 12, 2024
A. As
				  used in this chapter, "deli-style sales" means a purchase of medical cannabis
				  by a qualified patient or caregiver on the premises of a licensed dispensary
				  during which a dispensary agent weighs and packages the medical cannabis flower
				  in the dispensing service area while in the presence of the patient or
				  caregiver.
B. Standard Operating
				  Procedures.
(1) Each licensed dispensary
				  shall develop written standard operating procedures approved by the Commission
				  that address all aspects of deli-style sales including:
(a) The weighing, labelling, and repackaging
				  of the medical cannabis; and
(b)
				  Appropriate location, security, and records.
Code of Maryland Regulations › Title 10 - MARYLAND DEPARTMENT OF HEALTH › Part 5 › Subtitle 62 - NATALIE M. LAPRADE MEDICAL CANNABIS COMMISSION › Chapter 10.62.30 - Dispensing Medical Cannabis › Section 10.62.30.10 - Product Returned for Destruction

Current through Register Vol. 51, No. 14, July 12, 2024
A licensee shall:
A. Accept and record the return of any
				  medical cannabis from a qualifying patient or a caregiver; and
B. Destroy the returned medical
				  cannabis.
Code of Maryland Regulations › Title 10 - MARYLAND DEPARTMENT OF HEALTH › Part 5 › Subtitle 62 - NATALIE M. LAPRADE MEDICAL CANNABIS COMMISSION › Chapter 10.62.31 - Licensed Dispensary Clinical Director › Section 10.62.31.01 - Clinical Director Responsibilities

Current through Register Vol. 51, No. 14, July 12, 2024
A.
				  A licensed dispensary shall appoint an individual to function as clinical
				  director who:
(1) Is eligible to serve as a
				  certifying provider, as defined in Health-General Article, § 13-3301,
				  Annotated Code of Maryland;
(2) Is
				  a licensed pharmacist in good standing with the State Board of Pharmacy;
				  or
(3) Has substantial education,
				  training, and experience in the medical use of cannabis, as determined by the
				  Commission.
Code of Maryland Regulations › Title 10 - MARYLAND DEPARTMENT OF HEALTH › Part 5 › Subtitle 62 - NATALIE M. LAPRADE MEDICAL CANNABIS COMMISSION › Chapter 10.62.32 - Records › Section 10.62.32.01 - Definition

Current through Register Vol. 51, No. 14, July 12, 2024
In this chapter, "Licensee" means a licensed grower, a
					 licensed processor, and a licensed dispensary.
Code of Maryland Regulations › Title 10 - MARYLAND DEPARTMENT OF HEALTH › Part 5 › Subtitle 62 - NATALIE M. LAPRADE MEDICAL CANNABIS COMMISSION › Chapter 10.62.32 - Records › Section 10.62.32.02 - Licensee Records

Current through Register Vol. 51, No. 14, July 12, 2024
A. A
				  licensee shall maintain, independent of the inventory control, a searchable,
				  secure, tamper-evident record of each distribution that contains:
(1) The name and address of the
				  recipient;
(2) The quantity
				  delivered; and
(3) The name,
				  strength, batch number and lot number of the product.
Code of Maryland Regulations › Title 10 - MARYLAND DEPARTMENT OF HEALTH › Part 5 › Subtitle 62 - NATALIE M. LAPRADE MEDICAL CANNABIS COMMISSION › Chapter 10.62.32 - Records › Section 10.62.32.03 - Records Retention

Current through Register Vol. 51, No. 14, July 12, 2024
Unless otherwise specified, a licensee, or a certifying
					 provider shall retain a record for a period of 5 years.
Code of Maryland Regulations › Title 10 - MARYLAND DEPARTMENT OF HEALTH › Part 5 › Subtitle 62 - NATALIE M. LAPRADE MEDICAL CANNABIS COMMISSION › Chapter 10.62.33 - Inspection › Section 10.62.33.01 - Definition

Current through Register Vol. 51, No. 14, July 12, 2024
In this chapter, "Inspector" means any member of the
					 Commission or any State employee or contractor designated by the Commission to
					 carry out an inspection under this chapter.
Code of Maryland Regulations › Title 10 - MARYLAND DEPARTMENT OF HEALTH › Part 5 › Subtitle 62 - NATALIE M. LAPRADE MEDICAL CANNABIS COMMISSION › Chapter 10.62.33 - Inspection › Section 10.62.33.02 - Consent to Inspection

Current through Register Vol. 51, No. 14, July 12, 2024
Submission of an application to be a licensed grower,
					 licensed processor, or licensed dispensary, independent testing laboratory
					 irrevocably gives the Commission consent to conduct all inspections necessary
					 to ensure compliance with State law and regulations.
Code of Maryland Regulations › Title 10 - MARYLAND DEPARTMENT OF HEALTH › Part 5 › Subtitle 62 - NATALIE M. LAPRADE MEDICAL CANNABIS COMMISSION › Chapter 10.62.33 - Inspection › Section 10.62.33.03 - Inspection of Applicants

Current through Register Vol. 51, No. 14, July 12, 2024
A. The
				  Commission may inspect all premises of an applicant to be:
(1) A licensed grower;
(2) A licensed processor;
(3) A licensed dispensary; or
(4) A independent testing
				  laboratory.
Code of Maryland Regulations › Title 10 - MARYLAND DEPARTMENT OF HEALTH › Part 5 › Subtitle 62 - NATALIE M. LAPRADE MEDICAL CANNABIS COMMISSION › Chapter 10.62.33 - Inspection › Section 10.62.33.04 - Announced and Unannounced Inspections

Current through Register Vol. 51, No. 14, July 12, 2024
A. The Commission may conduct announced and
				  unannounced inspections of the facilities of licensed growers, licensed
				  processors, licensed dispensaries, and independent testing laboratories subject
				  to the Commission's regulation, mission, and function, to determine compliance
				  with statute and regulations.
B.
				  Failure by a licensed grower, licensed processor, licensed dispensary or
				  registered independent testing laboratory to provide the Commission with
				  immediate access to any part of a premises, requested material, information, or
				  agent as part of an inspection may result in the imposition of a civil fine,
				  suspension of license, or revocation of license.
C. During an inspection, the Commission may:
(1) Review and make copies of all
				  records;
(2) Enter any place,
				  including a vehicle, in which medical cannabis is held, dispensed, sold,
				  produced, tested, delivered, transported, manufactured or otherwise disposed
				  of;
(3) Inspect all equipment, raw
				  and processed material, containers and labeling, and all things therein
				  including:
(a) Records;
(b) Files;
(c) Financial data;
(d) Sales data;
(e) Shipping data;
(f) Pricing data;
(g) Employee data;
(h) Research;
(i) Papers;
(j) Processes;
(k) Controls; and
(l) Facilities;
(4) Inventory any medical cannabis;
(5) Inspect any equipment, instruments, tools
				  or machinery used to process:
(a) Medical
				  cannabis;
(b) Medical cannabis
				  concentrate; or
(c) Medical
				  cannabis-infused product; and
(6) Question personnel present at the
				  location and any agent of the licensee.
Code of Maryland Regulations › Title 10 - MARYLAND DEPARTMENT OF HEALTH › Part 5 › Subtitle 62 - NATALIE M. LAPRADE MEDICAL CANNABIS COMMISSION › Chapter 10.62.33 - Inspection › Section 10.62.33.05 - Sample Collection and Testing as Part of Inspection

Current through Register Vol. 51, No. 14, July 12, 2024
A. During an inspection, the Commission may
				  obtain samples for testing of any:
(1)
				  Cannabis;
(2) Medical cannabis
				  concentrate;
(3) Medical
				  cannabis-infused product;
(4)
				  Media used to grow cannabis;
(5)
				  Chemicals or solvents used to process medical cannabis concentrate;
(6) Labels or containers for
				  cannabis;
(7)
				  Paraphernalia;
(8) Any waste
				  material; and
(9) Raw or processed
				  material.
Code of Maryland Regulations › Title 10 - MARYLAND DEPARTMENT OF HEALTH › Part 5 › Subtitle 62 - NATALIE M. LAPRADE MEDICAL CANNABIS COMMISSION › Chapter 10.62.33 - Inspection › Section 10.62.33.06 - Action Upon Findings in Inspection

Current through Register Vol. 51, No. 14, July 12, 2024
A. In the event
				  that an inspector has reasonable suspicion of an operational failure or of
				  conditions that create a likelihood of diversion, contamination, or a risk to
				  public health:
(1) An inspector may:
(a) Suspend the distribution of some or all
				  medical cannabis from the licensed or registered premises;
(b) Order immediate evacuation of the
				  premises and seal the entry door; or
(c) Quarantine some or all medical cannabis;
Code of Maryland Regulations › Title 10 - MARYLAND DEPARTMENT OF HEALTH › Part 5 › Subtitle 62 - NATALIE M. LAPRADE MEDICAL CANNABIS COMMISSION › Chapter 10.62.33 - Inspection › Section 10.62.33.07 - Receipt and Chain of Custody for Materials Removed

Current through Register Vol. 51, No. 14, July 12, 2024
The Commission shall leave a receipt and create a
					 documented chain of custody for anything removed in the course of an
					 inspection
Code of Maryland Regulations › Title 10 - MARYLAND DEPARTMENT OF HEALTH › Part 5 › Subtitle 62 - NATALIE M. LAPRADE MEDICAL CANNABIS COMMISSION › Chapter 10.62.33 - Inspection › Section 10.62.33.08 - Report of Inspection

Current through Register Vol. 51, No. 14, July 12, 2024
A. An
				  inspector shall:
(1) Prepare a report of:
(a) The observations and findings of the
				  inspection; and
(b) Any demands
				  for corrective action;
Code of Maryland Regulations › Title 10 - MARYLAND DEPARTMENT OF HEALTH › Part 5 › Subtitle 62 - NATALIE M. LAPRADE MEDICAL CANNABIS COMMISSION › Chapter 10.62.34 - Discipline and Enforcement › Section 10.62.34.01 - Operational Failure Risking Diversion or Endangering Health

Current through Register Vol. 51, No. 14, July 12, 2024
A. A licensee, registrant, agent, or employee
				  may not divert or contaminate medical cannabis, or otherwise risk the health of
				  a patient or any other individual.
B. A licensee, registrant, agent, or employee
				  who violates §A of this regulation is subject to a fine of up to $10,000
				  per violation. The licensee, registrant, agent, or employee may:
(1) Elect to pay the imposed fine;
				  or
(2) Request a hearing not later
				  than 30 days after receipt of notice of the fine.
Code of Maryland Regulations › Title 10 - MARYLAND DEPARTMENT OF HEALTH › Part 5 › Subtitle 62 - NATALIE M. LAPRADE MEDICAL CANNABIS COMMISSION › Chapter 10.62.34 - Discipline and Enforcement › Section 10.62.34.02 - Pattern of Deviation from Standard Operating Procedure

Current through Register Vol. 51, No. 14, July 12, 2024
A. A licensee or registrant may not
				  substantially deviate or demonstrate a pattern of deviation from the standard
				  operating procedures or the terms set forth in the license.
B. A licensee, registrant, agent, or employee
				  who violates §A of this regulation is subject to a fine of up to $5,000
				  per violation. The licensee, registrant, agent, or employee may:
(1) Elect to pay the imposed fine;
				  or
(2) Request a hearing not later
				  than 30 days after receipt of notice of the fine.
Code of Maryland Regulations › Title 10 - MARYLAND DEPARTMENT OF HEALTH › Part 5 › Subtitle 62 - NATALIE M. LAPRADE MEDICAL CANNABIS COMMISSION › Chapter 10.62.34 - Discipline and Enforcement › Section 10.62.34.03 - Violation of Requirements

Current through Register Vol. 51, No. 14, July 12, 2024
A. A
				  licensee, registrant, agent, or employee may not violate a requirement of this
				  subtitle or Health-General Article, §§ 13-3301 - 13-3316, Annotated
				  Code of Maryland.
B. A licensee,
				  registrant, agent, or employee who violates §A of this regulation is
				  subject to a fine of up to $5,000 per violation. The licensee, registrant,
				  agent, or employee may:
(1) Elect to pay the
				  imposed fine; or
(2) Request a
				  hearing not later than 30 days after receipt of notice of the fine.
Code of Maryland Regulations › Title 10 - MARYLAND DEPARTMENT OF HEALTH › Part 5 › Subtitle 62 - NATALIE M. LAPRADE MEDICAL CANNABIS COMMISSION › Chapter 10.62.34 - Discipline and Enforcement › Section 10.62.34.04 - Action Against a Provider

Current through Register Vol. 51, No. 14, July 12, 2024
A. After
				  written notice and a hearing in accordance with the State Government Article,
				  §§ 10-201-10 -226, Annotated Code of Maryland, the Commission may
				  deny a certifying provider's application for registration, or revoke
				  registration to certify if the provider:
(1)
				  Fraudulently applied for approval;
(2) Fraudulently issued a written
				  certification; or
(3) Failed to
				  comply with this chapter.
Code of Maryland Regulations › Title 10 - MARYLAND DEPARTMENT OF HEALTH › Part 5 › Subtitle 62 - NATALIE M. LAPRADE MEDICAL CANNABIS COMMISSION › Chapter 10.62.34 - Discipline and Enforcement › Section 10.62.34.05 - Hearing Procedures

Current through Register Vol. 51, No. 14, July 12, 2024
A hearing held by the Commission or a designee of the
					 Commission will use the procedures set forth in COMAR
					 10.01.03.
Code of Maryland Regulations › Title 10 - MARYLAND DEPARTMENT OF HEALTH › Part 5 › Subtitle 62 - NATALIE M. LAPRADE MEDICAL CANNABIS COMMISSION › Chapter 10.62.34 - Discipline and Enforcement › Section 10.62.34.06 - Summary Suspension

Current through Register Vol. 51, No. 14, July 12, 2024
A. The
				  Commission shall order the summary suspension of a license or registration if
				  the Commission determines that the threat to public health, safety, or welfare
				  requires the immediate suspension of the license or registration.
B. The Commission shall promptly give the
				  licensee or registrant:
(1) Written notice of
				  the suspension, the findings, and the reasons that support the findings;
				  and
(2) An opportunity for a
				  hearing before the Commission.
Code of Maryland Regulations › Title 10 - MARYLAND DEPARTMENT OF HEALTH › Part 5 › Subtitle 62 - NATALIE M. LAPRADE MEDICAL CANNABIS COMMISSION › Chapter 10.62.34 - Discipline and Enforcement › Section 10.62.34.07 - Payment of Penalty

Current through Register Vol. 51, No. 14, July 12, 2024
The Commission shall remit any penalty collected under this
					 subtitle into the Natalie M. LaPrade Medical Cannabis Commission
					 Fund.
Code of Maryland Regulations › Title 10 - MARYLAND DEPARTMENT OF HEALTH › Part 5 › Subtitle 62 - NATALIE M. LAPRADE MEDICAL CANNABIS COMMISSION › Chapter 10.62.34 - Discipline and Enforcement › Section 10.62.34.08 - Advertising Restrictions

Current through Register Vol. 51, No. 14, July 12, 2024
A. All
				  advertisements for medical cannabis, medical cannabis products, edible cannabis
				  products, and medical cannabis-related services shall comply with the
				  requirements of Health-General Article, § 13-3313.1, Annotated Code of
				  Maryland.
B. A licensee,
				  registrant, agent, or employee who violates §A of this regulation:
(1) Is subject to a fine not exceeding:
(a) $500 for a first violation;
(b) $1,000 for a second violation occurring
				  within 24 months after the first violation; and
(c) $5,000 for each subsequent violation
				  occurring within 24 months after the preceding violation; and
Code of Maryland Regulations › Title 10 - MARYLAND DEPARTMENT OF HEALTH › Part 5 › Subtitle 62 - NATALIE M. LAPRADE MEDICAL CANNABIS COMMISSION › Chapter 10.62.34 - Discipline and Enforcement › Section 10.62.34.09 - Fine Schedule

Current through Register Vol. 51, No. 14, July 12, 2024
Any fine the Commission imposes upon a licensee,
					 registrant, agent, or employee for a violation of this subtitle or
					 Health-General Article, §§ 13-3301-13 -3316, Annotated Code of
					 Maryland, shall comply with the fine schedule adopted by the Commission and
					 posted on the Commission's website.
Code of Maryland Regulations › Title 10 - MARYLAND DEPARTMENT OF HEALTH › Part 5 › Subtitle 62 - NATALIE M. LAPRADE MEDICAL CANNABIS COMMISSION › Chapter 10.62.35 - Fee Schedule › Section 10.62.35.01 - Fees

Current through Register Vol. 51, No. 14, July 12, 2024
The following fees are established by the
					 Commission:
A. Grower fees:
(1) License as Grower-only:
(a) Application fee - $6,000 (Stage 1:
				  $2,000; Stage 2: $4,000); and
(b)
				  Annual license fee - $125,000; and
Code of Maryland Regulations › Title 10 - MARYLAND DEPARTMENT OF HEALTH › Part 5 › Subtitle 62 - NATALIE M. LAPRADE MEDICAL CANNABIS COMMISSION › Chapter 10.62.36 - Academic Research › Section 10.62.36.01 - Definitions

Current through Register Vol. 51, No. 14, July 12, 2024
A. In this
				  chapter, the following terms have the meanings indicated.
B. Terms Defined.
(1) "Academic research institution" means an
				  institution of higher education, a related medical facility, or an affiliated
				  biomedical research firm that filed a registration with the Commission under
				  Health-General Article, § 13-3304.1, Annotated Code of Maryland, to
				  purchase medical cannabis for the purpose of conducting a bona fide research
				  project.
(2) 'Academic research
				  representative" has the meaning stated in Health-General Article, §
				  13-3301, Annotated Code of Maryland.
(3) Institution of Higher Education.
(a) "Institution of higher education " means
				  an institution of postsecondary education lawfully operating in the State that
				  generally limits enrollment to graduates of secondary schools, and awards
				  degrees at the associate, baccalaureate, or graduate level.
(b) "Institution of higher education"
				  includes public, independent, and private nonprofit and for-profit institutions
				  of higher education.
(4)
				  "Research protocol" means a written plan for conducting a bona fide research
				  project relating to the health effects, medical uses, properties, or
				  composition of medical cannabis that includes the following information:
(a) Name, address, date of birth, Social
				  Security number, institutional affiliation, and qualifications, including a
				  curriculum vitae and list of publications, for the primary
				  researcher;
(b) Title, expected
				  duration, primary objectives, statement of purpose, and description of the bona
				  fide research project;
(c) Type and
				  amount of medical cannabis or medical cannabis products, and the dosage, route,
				  and method of administration necessary to conduct the bona fide research
				  project; and
(d) Standard operating
				  procedures for the safe and secure receipt, storage, packaging, labeling,
				  handling, tracking, and dispensing of products containing medical cannabis and
				  green waste.
Code of Maryland Regulations › Title 10 - MARYLAND DEPARTMENT OF HEALTH › Part 5 › Subtitle 62 - NATALIE M. LAPRADE MEDICAL CANNABIS COMMISSION › Chapter 10.62.36 - Academic Research › Section 10.62.36.02 - Academic Research Institution Registration

Current through Register Vol. 51, No. 14, July 12, 2024
A. An academic research institution shall
				  register with the Commission in order to purchase, through an academic research
				  representative, medical cannabis from a licensed grower, processor, or
				  dispensary in Maryland.
B. To
				  register, an academic research institution shall submit:
(1) The academic research institution
				  registration fee specified in COMAR 10.62.35; and
(2) A completed academic research institution
				  registration form provided by the Commission, including a research
				  protocol.
Code of Maryland Regulations › Title 10 - MARYLAND DEPARTMENT OF HEALTH › Part 5 › Subtitle 62 - NATALIE M. LAPRADE MEDICAL CANNABIS COMMISSION › Chapter 10.62.36 - Academic Research › Section 10.62.36.03 - Academic Research Representative Registration and Criminal History Record

Current through Register Vol. 51, No. 14, July 12, 2024
A. An academic
				  research representative shall be registered with the Commission before the
				  representative may purchase medical cannabis for a registered academic research
				  institution.
B. A registered
				  academic research institution shall apply to register an academic research
				  representative by submitting to the Commission:
(1) The academic research institution
				  representative fee specified in COMAR 10.62.35 for each academic research
				  representative; and
(2) A
				  completed academic research representative registration form provided by the
				  Commission.
Code of Maryland Regulations › Title 10 - MARYLAND DEPARTMENT OF HEALTH › Part 5 › Subtitle 62 - NATALIE M. LAPRADE MEDICAL CANNABIS COMMISSION › Chapter 10.62.36 - Academic Research › Section 10.62.36.04 - Purchase of Medical Cannabis

Current through Register Vol. 51, No. 14, July 12, 2024
A. The
				  Commission-issued identification card allows a registered academic research
				  representative to purchase the type and amount of medical cannabis specified in
				  the research protocol from a licensed grower, processor, or
				  dispensary.
B. Prior to obtaining
				  the medical cannabis, the registered academic research representative shall
				  submit to the Commission for approval a copy of a written authorization from
				  the academic research institution to purchase medical cannabis for the purpose
				  of conducting a bona fide research project.
C. The written authorization shall include:
(1) The period that the authorization to
				  possess the medical cannabis remains in effect;
(2) The quantity of the medical cannabis
				  requested; and
(3) Any other
				  special requirements.
Code of Maryland Regulations › Title 10 - MARYLAND DEPARTMENT OF HEALTH › Part 5 › Subtitle 62 - NATALIE M. LAPRADE MEDICAL CANNABIS COMMISSION › Chapter 10.62.36 - Academic Research › Section 10.62.36.05 - Inspection and Reporting Requirements

Current through Register Vol. 51, No. 14, July 12, 2024
A.
				  Submission of a registration form under Regulation .02 of this chapter gives
				  the Commission consent to conduct at least two inspections per year, one
				  announced and one unannounced, to ensure compliance with State law and
				  regulations.
B. The Commission may
				  inspect all premises of a registered academic research institution used to
				  conduct research relating to medical cannabis to determine that:
(1) The research using medical cannabis is
				  ongoing and consistent with the associated research protocol;
(2) The academic research institution
				  provides for the safe, secure storage of the medical cannabis; and
(3) There is written documentation of the
				  chain of custody of the medical cannabis.
Code of Maryland Regulations › Title 10 - MARYLAND DEPARTMENT OF HEALTH › Part 5 › Subtitle 62 - NATALIE M. LAPRADE MEDICAL CANNABIS COMMISSION › Chapter 10.62.36 - Academic Research › Section 10.62.36.06 - Term and Renewal

Current through Register Vol. 51, No. 14, July 12, 2024
A. The
				  registration is valid for the term indicated on the registration form approved
				  by the Commission.
B. The
				  registrant may apply for an extension of the registration beginning 90 days
				  before the expiration of the registration.
C. The registration shall remain valid
				  unless:
(1) There is a change in the research
				  project; or
(2) The academic
				  research institution withdraws the registration.
Code of Maryland Regulations › Title 10 - MARYLAND DEPARTMENT OF HEALTH › Part 5 › Subtitle 62 - NATALIE M. LAPRADE MEDICAL CANNABIS COMMISSION › Chapter 10.62.37 - Edible Cannabis Products › Section 10.62.37.01 - Definitions

Current through Register Vol. 51, No. 14, July 12, 2024
A. In this
				  chapter, the following terms have the meanings indicated.
B. Terms Defined.
(1) "Approved source" means a source of:
(a) Medical cannabis approved, licensed, and
				  regulated by the Commission; or
(b)
				  Food ingredients regulated by an approving authority.
Code of Maryland Regulations › Title 10 - MARYLAND DEPARTMENT OF HEALTH › Part 5 › Subtitle 62 - NATALIE M. LAPRADE MEDICAL CANNABIS COMMISSION › Chapter 10.62.37 - Edible Cannabis Products › Section 10.62.37.02 - Categorization as Edible Cannabis Products

Current through Register Vol. 51, No. 14, July 12, 2024
Food or a food ingredient that is mixed, infused, or comes
					 into contact with medical cannabis is considered and regulated as an edible
					 cannabis product under this chapter.
Code of Maryland Regulations › Title 10 - MARYLAND DEPARTMENT OF HEALTH › Part 5 › Subtitle 62 - NATALIE M. LAPRADE MEDICAL CANNABIS COMMISSION › Chapter 10.62.37 - Edible Cannabis Products › Section 10.62.37.03 - Issuance of Permit

Current through Register Vol. 51, No. 14, July 12, 2024
A. Before
				  engaging in the business of possessing, processing, packaging, labeling,
				  transferring, transporting, selling, or distributing to a dispensary edible
				  cannabis products, a licensed processor shall obtain a permit from the
				  Commission.
B. To obtain a permit,
				  a licensed processor shall:
(1) Submit a
				  completed permit application;
(2)
				  Pay the registration fee specified in COMAR 10.62.35;
(3) Establish and obtain Commission approval
				  for each of the standard operating procedures required by this
				  chapter;
(4) Pass a pre-operation
				  inspection; and
(5) Conspicuously
				  post applicable State and local licenses at the licensed premises.
Code of Maryland Regulations › Title 10 - MARYLAND DEPARTMENT OF HEALTH › Part 5 › Subtitle 62 - NATALIE M. LAPRADE MEDICAL CANNABIS COMMISSION › Chapter 10.62.37 - Edible Cannabis Products › Section 10.62.37.04 - General Premises Requirements

Current through Register Vol. 51, No. 14, July 12, 2024
A. The
				  premises and operations shall conform to all local zoning and planning
				  requirements.
B. A permit to
				  process edible cannabis products shall be conspicuously displayed at the
				  premises.
C. No major renovation or
				  modification to the premises may be undertaken unless the Commission:
(1) Has received notice in the form
				  prescribed by the Commission; and
(2) Issues written approval for the
				  renovation or modification.
Code of Maryland Regulations › Title 10 - MARYLAND DEPARTMENT OF HEALTH › Part 5 › Subtitle 62 - NATALIE M. LAPRADE MEDICAL CANNABIS COMMISSION › Chapter 10.62.37 - Edible Cannabis Products › Section 10.62.37.05 - Receipt of Ingredients

Current through Register Vol. 51, No. 14, July 12, 2024
A.
				  Ingredients and other supplies necessary to process edible cannabis products
				  shall be received in a designated area identified in the standard operating
				  procedures.
B. This regulation does
				  not apply to the receipt of medical cannabis, medical cannabis concentrates, or
				  medical cannabis-infused products that are not intended to be used as an
				  ingredient in edible cannabis products.
C. Each receiving area shall have a barrier
				  that reasonably prevents the entry of:
(1)
				  Insects;
(2) Vermin;
(3) Pathogenic microorganisms;
(4) Toxic or deleterious chemicals;
(5) Foreign matter;
(6) Dust; or
(7) Animals.
Code of Maryland Regulations › Title 10 - MARYLAND DEPARTMENT OF HEALTH › Part 5 › Subtitle 62 - NATALIE M. LAPRADE MEDICAL CANNABIS COMMISSION › Chapter 10.62.37 - Edible Cannabis Products › Section 10.62.37.06 - Storage of Ingredients and Edible Cannabis Products

Current through Register Vol. 51, No. 14, July 12, 2024
A. All ingredients and edible cannabis
				  products shall be kept in a secure controlled environment that:
(1) Meets the requirements set forth in this
				  chapter; and
(2) Is a dry storage
				  area, refrigerated storage area, or freezer storage area.
Code of Maryland Regulations › Title 10 - MARYLAND DEPARTMENT OF HEALTH › Part 5 › Subtitle 62 - NATALIE M. LAPRADE MEDICAL CANNABIS COMMISSION › Chapter 10.62.37 - Edible Cannabis Products › Section 10.62.37.07 - Equipment

Current through Register Vol. 51, No. 14, July 12, 2024
A. General
				  Requirements.
(1) The permittee shall prevent
				  any ingredient or edible cannabis product from coming into contact with a
				  surface or substance other than a clean and sanitary surface or substance
				  intended for food contact or incorporation into food.
(2) Any heating and cooling equipment in
				  close contact with ingredients or edible cannabis products shall be:
(a) Food grade;
(b) Approved for use in food processing
				  areas; or
(c) Designed to prevent
				  any contact with any ingredient or edible cannabis product.
(3) The permittee shall ensure
				  that:
(a) The warewashing area includes a
				  three-compartment sink able to hold and wash cookware and equipment in the
				  kitchen;
(b) Larger cookware or
				  equipment that cannot have at least 50 percent of its contact surface submerged
				  in the three-compartment sink complies with approved standard operating
				  procedures for cleaning and sanitizing the cookware or equipment;
(c) Agents are trained to clean the larger
				  cookware and equipment according to the standard operating procedures;
				  and
(d) A log is maintained for 2
				  years detailing the date, time, and agent responsible for cleaning and
				  sanitizing the larger cookware or equipment.
(4) Equipment used to process ingredients and
				  edible cannabis products shall be:
(a)
				  Maintained in a sanitary and working condition;
(b) Tested and calibrated according to the
				  equipment manufacturer's instructions to ensure accuracy; and
(c) Positioned in a manner that does not
				  impede proper cleaning and sanitation procedures.
(5) Equipment used to process ingredients and
				  edible cannabis products shall meet design standards intended for food
				  production equipment, such as those established by the:
(a) National Sanitation Foundation
				  (NSF);
(b) Bakery Industry
				  Sanitation Standards Committee;
(c)
				  National Automatic Merchandising Association;
(d) International Association of Milk and
				  Food Sanitarians;
(e) American
				  Society of Mechanical Engineers; or
(f) U.S. Department of Agriculture.
(6) A thermometer used to monitor
				  the temperature of any ingredient, edible cannabis product, or storage area
				  shall be:
(a) Validated at least once per
				  month using standard operating procedures approved by the Commission;
				  and
(b) Calibrated based on the
				  manufacturer's recommendations to ensure accuracy, and at a minimum:
(i) Annually; or
(ii) When validation procedures identify a
				  thermometer is not accurate to plus or minus 2°F.
Code of Maryland Regulations › Title 10 - MARYLAND DEPARTMENT OF HEALTH › Part 5 › Subtitle 62 - NATALIE M. LAPRADE MEDICAL CANNABIS COMMISSION › Chapter 10.62.37 - Edible Cannabis Products › Section 10.62.37.08 - Cleaning and Sanitation Procedures

Current through Register Vol. 51, No. 14, July 12, 2024
A. General
				  Requirements.
(1) A permittee shall establish
				  standard operating procedures for cleaning and sanitizing any surface,
				  cookware, or equipment that comes into contact with ingredients or edible
				  cannabis products that:
(a) Ensure proper
				  sanitation throughout the premises;
(b) Are available to each agent in a form the
				  agent understands; and
(c) Are
				  approved by the Commission.
Code of Maryland Regulations › Title 10 - MARYLAND DEPARTMENT OF HEALTH › Part 5 › Subtitle 62 - NATALIE M. LAPRADE MEDICAL CANNABIS COMMISSION › Chapter 10.62.37 - Edible Cannabis Products › Section 10.62.37.10 - Manufacture

Current through Register Vol. 51, No. 14, July 12, 2024
A. A
				  permittee shall establish standard operating procedures to ensure the
				  consistent and safe manufacture of edible cannabis products.
B. A standard operating procedure for the
				  manufacture of edible cannabis products shall:
(1) Be available to each agent in a form the
				  agent understands;
(2) Accurately
				  reflect the procedures used at the premises; and
(3) Be approved by the Commission.
Code of Maryland Regulations › Title 10 - MARYLAND DEPARTMENT OF HEALTH › Part 5 › Subtitle 62 - NATALIE M. LAPRADE MEDICAL CANNABIS COMMISSION › Chapter 10.62.37 - Edible Cannabis Products › Section 10.62.37.11 - Trade Secrets

Current through Register Vol. 51, No. 14, July 12, 2024
A. A permittee
				  shall provide the Commission with the recipe for each edible cannabis product
				  prior to offering the product for distribution or sale to a licensed
				  dispensary.
B. A permittee shall
				  notify the Commission of any ingredient or recipe that the permittee considers
				  a trade secret.
C. The Commission
				  shall maintain the confidentiality of trade secret information in accordance
				  with State Government Article, §
										10-617, and
				  Health-General Article, § 21-259, Annotated Code of Maryland.
D. If the Commission determines that the
				  information about an ingredient or recipe is necessary to conduct a disease
				  outbreak investigation, the Commission may disclose the trade secret to the
				  appropriate investigators.
Code of Maryland Regulations › Title 10 - MARYLAND DEPARTMENT OF HEALTH › Part 5 › Subtitle 62 - NATALIE M. LAPRADE MEDICAL CANNABIS COMMISSION › Chapter 10.62.37 - Edible Cannabis Products › Section 10.62.37.12 - Edible Cannabis Product Requirements

Current through Register Vol. 51, No. 14, July 12, 2024
A. General
				  Requirements.
(1) A permittee shall obtain
				  approval from the Commission for all edible cannabis products prior to offering
				  the products for distribution or sale to a licensed dispensary by submitting a
				  request in the perpetual inventory control system.
(2) A permittee seeking approval to offer an
				  edible cannabis product shall submit:
(a) A
				  photograph, digital image, or digital rendering of the product, labeling, and
				  packaging;
(b) The varying levels
				  of potency and dosing of the edible cannabis product;
(c) The recipe, including the production
				  process, for manufacturing the edible cannabis product; and
(d) Any scientific studies or laboratory
				  testing results supporting the stability and approximate expiration date of the
				  edible cannabis product.
(3) The Commission shall review and approve
				  each edible cannabis product before the product may be commercially
				  manufactured or sold by a permittee, to ensure the:
(a) Product complies with the requirements of
				  this chapter; and
(b) Safety of
				  minors.
Code of Maryland Regulations › Title 10 - MARYLAND DEPARTMENT OF HEALTH › Part 5 › Subtitle 62 - NATALIE M. LAPRADE MEDICAL CANNABIS COMMISSION › Chapter 10.62.37 - Edible Cannabis Products › Section 10.62.37.13 - Edible Cannabis Packaging Requirements

Current through Register Vol. 51, No. 14, July 12, 2024
A. All edible cannabis product packaging
				  shall comply with the requirements established in COMAR 10.62.24 and COMAR
				  10.62.29.
B. Any container or
				  packaging containing edible cannabis products shall protect the contents from
				  contamination.
C. Edible cannabis
				  product packaging:
(1) Shall be designed and
				  installed to maintain product safety and integrity;
(2) Shall be made from materials that are
				  food safe, are appropriate for the intended use, and cannot migrate to or be
				  absorbed by the edible cannabis product;
(3) Shall comply with the food additive
				  requirements established in 21 CFR §§ 174-178 ;
(4) Shall be tamper-evident;
(5) Shall comply with the child-resistant
				  packaging requirements established in 16 CFR § 1700 ;
(6) If intended for multiple openings, shall
				  be capable of being resealed and sustain being child-resistant after the
				  container or package has been opened;
(7) Shall be stored so that the edible
				  cannabis product is protected from contamination; and
(8) May not be reused.
Code of Maryland Regulations › Title 10 - MARYLAND DEPARTMENT OF HEALTH › Part 5 › Subtitle 62 - NATALIE M. LAPRADE MEDICAL CANNABIS COMMISSION › Chapter 10.62.37 - Edible Cannabis Products › Section 10.62.37.14 - Edible Cannabis Product Labeling Requirements

Current through Register Vol. 51, No. 14, July 12, 2024
A. An edible cannabis product label shall
				  comply with the requirements established in COMAR 10.62.24 and COMAR
				  10.62.29.
B. An edible cannabis
				  product label shall include:
(1) A list of:
(a) Ingredients and sub-ingredients in
				  descending order of prominence; and
(b) Any natural or synthetic preservative
				  added;
Code of Maryland Regulations › Title 10 - MARYLAND DEPARTMENT OF HEALTH › Part 5 › Subtitle 62 - NATALIE M. LAPRADE MEDICAL CANNABIS COMMISSION › Chapter 10.62.37 - Edible Cannabis Products › Section 10.62.37.15 - Limited Testing for Research and Development Purposes

Current through Register Vol. 51, No. 14, July 12, 2024
A. A licensed processor may process edible
				  cannabis products for research and development purposes to facilitate safe
				  edible cannabis product development and innovation.
B. The research and development of the edible
				  cannabis products under this regulation may not include testing of any type on
				  human or animal subjects.
C. Edible
				  Cannabis Product Development. A licensed processor who processes edible
				  cannabis products for research and development shall:
(1) Track the medical cannabis used for
				  research and development in the perpetual inventory control system;
(2) Quarantine each batch or lot in a
				  quarantine area and label each batch or lot with a distinctive label;
(3) Process the medical cannabis for research
				  and development during a time that does not overlap with the processing of any
				  medical cannabis that will be intended for human consumption; and
(4) Establish standard operating procedures
				  for cleaning and sanitation that:
(a) Include
				  protocols for adequately cleaning processing areas, cookware, and equipment in
				  between processing edible cannabis products for research and development
				  purposes and processing products intended for human consumption; and
(b) Are approved by the Commission.
Code of Maryland Regulations › Title 10 - MARYLAND DEPARTMENT OF HEALTH › Part 5 › Subtitle 62 - NATALIE M. LAPRADE MEDICAL CANNABIS COMMISSION › Chapter 10.62.37 - Edible Cannabis Products › Section 10.62.37.16 - Transport of Edible Cannabis Products

Current through Register Vol. 51, No. 14, July 12, 2024
A.
				  The transport of edible cannabis products shall comply with the medical
				  cannabis shipment requirements established in COMAR 10.62.18.
B. If transporting edible cannabis products
				  that require temperature control for safety and stability, a permittee shall
				  ensure the vehicle or transportation equipment:
(1) Provides adequate temperature control to
				  prevent the edible cannabis products from becoming unsafe during transport;
				  and
(2) Complies with the
				  requirements established in 21 CFR §
												1.908(c).
Code of Maryland Regulations › Title 10 - MARYLAND DEPARTMENT OF HEALTH › Part 5 › Subtitle 62 - NATALIE M. LAPRADE MEDICAL CANNABIS COMMISSION › Chapter 10.62.37 - Edible Cannabis Products › Section 10.62.37.17 - Dispensary Responsibilities

Current through Register Vol. 51, No. 14, July 12, 2024
A. A
				  licensed dispensary may not store or distribute edible cannabis products unless
				  the licensed dispensary:
(1) Submits to the
				  Commission the licensee's standard operating procedures for receipt, storage,
				  and distribution of all edible cannabis products; and
(2) Passes a Commission inspection, and the
				  operations conform to the standard operating procedures for the receipt,
				  storage, and distribution of all edible cannabis products.
Code of Maryland Regulations › Title 10 - MARYLAND DEPARTMENT OF HEALTH › Part 5 › Subtitle 62 - NATALIE M. LAPRADE MEDICAL CANNABIS COMMISSION › Chapter 10.62.37 - Edible Cannabis Products › Section 10.62.37.18 - Laboratory Testing

Current through Register Vol. 51, No. 14, July 12, 2024
A. Each lot of
				  edible cannabis products shall be tested by a registered independent testing
				  laboratory for:
(1) Cannabinoid content,
				  including:
(a) THC, which shall be +/-10
				  percent of any amount indicated on the edible cannabis product label;
(b) Any other cannabinoids indicated in the
				  Commission's current version of technical authority; and
(c) Any cannabinoid identified on the package
				  or label of the edible cannabis product;
Code of Maryland Regulations › Title 10 - MARYLAND DEPARTMENT OF HEALTH › Part 5 › Subtitle 62 - NATALIE M. LAPRADE MEDICAL CANNABIS COMMISSION › Chapter 10.62.37 - Edible Cannabis Products › Section 10.62.37.19 - Exceptions

Current through Register Vol. 51, No. 14, July 12, 2024
A licensee may not use an alternative method of receiving,
					 storing, sanitizing, delivering, processing, monitoring, or verifying edible
					 cannabis products or edible cannabis product equipment, cookware, or procedures
					 unless authorized by the Commission.
Code of Maryland Regulations › Title 10 - MARYLAND DEPARTMENT OF HEALTH › Part 5 › Subtitle 62 - NATALIE M. LAPRADE MEDICAL CANNABIS COMMISSION › Chapter 10.62.37 - Edible Cannabis Products › Section 10.62.37.20 - Compliance with State and Federal Food Safety Requirements

Current through Register Vol. 51, No. 14, July 12, 2024
Although edible cannabis products are not defined as or
					 regulated by the same approving authority as food, in addition to the other
					 requirements set forth in this chapter, a permittee shall comply with all
					 applicable food safety regulations including:
A. 21 CFR, as Regulation .01
				  adopted;
B.
										21 U.S.C. §
											343, as Regulation .01 adopted;
C.
										21 U.S.C. §§
											451 -
				  471, as Regulation .01 adopted;
				  and
D.
										21 U.S.C. §§
											601 -
				  695, as Regulation .01
				  adopted.
Code of Maryland Regulations › Title 10 - MARYLAND DEPARTMENT OF HEALTH › Part 5 › Subtitle 62 - NATALIE M. LAPRADE MEDICAL CANNABIS COMMISSION › Chapter 10.62.37 - Edible Cannabis Products › Section 10.62.37.21 - Medical Cannabis Products and Components Not Subject to This Chapter

Current through Register Vol. 51, No. 14, July 12, 2024
A. Regulations
				  .01-.19 of this chapter do not apply to the following:
(1) Dried leaves and flowers of the cannabis
				  plant;
(2) Medical cannabis
				  concentrates; and
(3) Medical
				  cannabis-infused products as defined in COMAR
				  10.62.23.01B(3)(c).
Code of Maryland Regulations › Title 10 - MARYLAND DEPARTMENT OF HEALTH › Part 5 › Subtitle 63 - COMMUNITY-BASED BEHAVIORAL HEALTH PROGRAMS AND SERVICES › Chapter 10.63.01 - Requirements for All Licensed Programs › Section 10.63.01.01 - Scope

Current through Register Vol. 51, No. 14, July 12, 2024
This chapter sets forth the definitions for this subtitle
					 and the requirement that a program be licensed to provide community behavioral
					 health treatment, care, or rehabilitation services.
Code of Maryland Regulations › Title 10 - MARYLAND DEPARTMENT OF HEALTH › Part 5 › Subtitle 63 - COMMUNITY-BASED BEHAVIORAL HEALTH PROGRAMS AND SERVICES › Chapter 10.63.01 - Requirements for All Licensed Programs › Section 10.63.01.03 - License Required

Current through Register Vol. 51, No. 14, July 12, 2024
A. Except
				  as provided in Regulation .04 of this chapter, an individual or entity shall
				  have a valid and current license issued by the Department under this subtitle
				  in order to provide community-based behavioral health services in
				  Maryland.
B. A license issued under
				  this subtitle may not be transferred.
Code of Maryland Regulations › Title 10 - MARYLAND DEPARTMENT OF HEALTH › Part 5 › Subtitle 63 - COMMUNITY-BASED BEHAVIORAL HEALTH PROGRAMS AND SERVICES › Chapter 10.63.01 - Requirements for All Licensed Programs › Section 10.63.01.04 - Exempt Providers

Current through Register Vol. 51, No. 14, July 12, 2024
A. In
				  accordance with Health-General Article, § 7.5 -401, Annotated Code of
				  Maryland, the following providers are exempt from the requirements of, and are
				  not required to be licensed under, this subtitle:
(1) Except as provided in §B of this
				  regulation:
(a) A health professional, in
				  either a solo practice or group practice, who is licensed under the Health
				  Occupations Article; and
(b) Is
				  providing services in accordance with the requirements of the appropriate
				  professional board;
Code of Maryland Regulations › Title 10 - MARYLAND DEPARTMENT OF HEALTH › Part 5 › Subtitle 63 - COMMUNITY-BASED BEHAVIORAL HEALTH PROGRAMS AND SERVICES › Chapter 10.63.01 - Requirements for All Licensed Programs › Section 10.63.01.05 - Requirements for Licensed Community-Based Behavioral Health Program

Current through Register Vol. 51, No. 14, July 12, 2024
A. A program
				  licensed under this subtitle to provide community-based behavioral health
				  services in Maryland shall comply with the requirements listed in this
				  regulation.
B. Post-Licensing
				  Inspections.
(1) The Department or its
				  designees may make announced or unannounced visits to inspect a program to
				  investigate a complaint.
(2) The
				  Department or its designees may inspect and copy records, including, but not
				  limited to:
(a) Financial records;
(b) Treatment records; and
(c) Service records.
Code of Maryland Regulations › Title 10 - MARYLAND DEPARTMENT OF HEALTH › Part 5 › Subtitle 63 - COMMUNITY-BASED BEHAVIORAL HEALTH PROGRAMS AND SERVICES › Chapter 10.63.02 - Programs Required to Be Accredited in Order to Be Licensed to Provide Community-Based Behavioral Health Services › Section 10.63.02.01 - Scope

Current through Register Vol. 51, No. 14, July 12, 2024
This chapter identifies those programs that are required to
					 be accredited in order to receive a license to provide community-based
					 behavioral health services.
Code of Maryland Regulations › Title 10 - MARYLAND DEPARTMENT OF HEALTH › Part 5 › Subtitle 63 - COMMUNITY-BASED BEHAVIORAL HEALTH PROGRAMS AND SERVICES › Chapter 10.63.02 - Programs Required to Be Accredited in Order to Be Licensed to Provide Community-Based Behavioral Health Services › Section 10.63.02.02 - Covered Programs and Services

Current through Register Vol. 51, No. 14, July 12, 2024
A. The
				  following programs shall require an accreditation-based license under this
				  chapter:
(1) Group Homes for Adults with
				  Mental Illness programs;
(2)
				  Integrated Behavioral Health programs;
(3) Intensive Outpatient Treatment Level 2.1
				  programs;
(4) Mobile Treatment
				  Services (MTS) programs;
(5)
				  Outpatient Mental Health Center (OMHC) programs;
(6) Outpatient Treatment Level 1
				  programs;
(7) Partial
				  Hospitalization Treatment Level 2.5 programs;
(8) Psychiatric Day Treatment Program (PDTP)
				  programs;
(9) Psychiatric
				  Rehabilitation Program for Adults (PRP-A) programs;
(10) Psychiatric Rehabilitation Program for
				  Minors (PRP-M) programs;
(11)
				  Residential Crisis Services (RCS) programs;
(12) Residential: Low Intensity Level 3.1
				  programs;
(13) Residential: Medium
				  Intensity Level 3.3 programs;
(14)
				  Residential: High Intensity Level 3.5 programs;
(15) Residential: Intensive Level 3.7
				  programs;
(16) Residential
				  Rehabilitation Program (RRP) programs;
(17) Respite Care Services (RPCS) programs;
(18) Supported Employment Program
				  (SEP) programs;
(19) Mobile Crisis
				  Team programs; and
(20) Behavioral
				  Health Crisis Stabilization Center (BHCSC) programs.